BioInsights – the publisher of Cell & Gene Therapy Insights - is your content marketing partner for life sciences.

Clinical Network Services (CNS) published an article on 20th July 2018 and on the 5th of August we received an enquiry through our website from a previously unknown company that answered the question “How did you hear about us?” with “Cell & Gene Therapy Insights publication”.

It is rare that you have such a tangible link between an activity and a totally new and serious business opportunity. We will be doing more with BioInsights on this basis.”
Paul Cronin, Director, Clinical Network Services (CNS)

About Cell & Gene Therapy Insights

Cell and Gene Therapy Insights is an online, peer-reviewed, open access journal with a translational focus. Key scientific, regulatory, business and manufacturing challenges and advances are addressed through publication of original research, reviews, commentary articles, clinical trial reports and much more.

All content is available free of charge, and the journal is complemented by daily news and engaging multimedia formats such as webinars, video and podcasts.

  • Is it important for your company to demonstrate its capabilities to scientists and/or business leaders making key technology platform decisions at an early stage in a product’s development?
  • Or perhaps you need to generate qualified leads from companies involved in viral vector manufacture?
  • Maybe you need to provide educational materials to individuals focused on clinical development or regulatory affairs?
Cell & Gene Therapy Insights provides a unique online content marketing and lead generation opportunity:
    • Active engagement of key stakeholders from across the global community all year round
    • The chance to target organizations at varying stages of the R&D pipeline: Universities, spin-outs, biotechs, pharma, hospitals, investors and analysts
    • An alternative to the ever-more-crowded and expensive conference market
    • Investors and analysts
    • A means by which you can access the people funding the sector, those making the key new discoveries, and the individuals driving the delivery of safe and effective therapies to patients
“As the field of Cell and Gene Therapy begins to show some of its early promise, we are reminded on a regular basis there are still many challenges ahead on the path to developing solutions for patients. This transition is where we still need to focus and learn how to utilise the great ideas of academics and start-ups alongside the experience and expertise of larger companies. The need for a translational journal focussed on bringing all of these groups together in a collaborative, open forum cannot be over-emphasized.”

Dr Sven Kili, VP & Head of Gene Therapy Development, GSK

What we do?

We can:

  • Work closely with you to create quality written and multimedia content of high value to your target audience
  • Offer you opportunities to re-purpose scientific and educational content you have already developed and make it available to a global audience
  • Raise your company’s profile, demonstrate your capabilities, and enhance your reputation as a thought-leader in the sector
  • Play a key role in your lead generation activities
  • Provide support in the development of your content marketing strategy and tactics for this sector
  • Ensure your leading scientists are seen as Subject Matter Experts throughout your target market
  • Help you disseminate your content to a global audience within cell therapy, gene therapy or tissue therapy.
Content marketing is all about partnership:

We can work closely with you – and your Scientific Advisory Board if you wish – to develop high quality content to demonstrate your thought-leadership:

  • Your own Spotlight, on a topic of your choice
  • Client case studies and co-presentations
  • Videos, animations and webinars

We seek to find out as much as we can about who you are targeting, and then work to ensure the maximum number of relevant individuals are interacting with your content

We don’t sell off-the-shelf solutions. All the packages we provide are tailored to your precise marketing, educational and business development objectives.


Who can you reach?

Cell & Gene Therapy Insights is designed as a year-round hub for stakeholders from across the community. View Cell & Gene Therapy Insights' Demographics


How can you reach them?

We offer a broad range of options, any of which can be tailored to match your current marketing and business development priorities. These include:


Who do we work with?

Our client list includes:

 

 

      • Aldevron
      • Alfa Wassermann
      • AmerisourceBergen
      • Aseptic Technologies SA
      • Be The Match BioTherapies
      • BioLife Solutions
      • Bio-Rad
      • Bio-Techne
      • Blood Centers of America
      • Brooks Automation
      • Cell & Gene Therapy Catapult
      • CellGenix GmbH
      • Cesca Therapeutics
      • Cevec Pharmaceuticals
      • Charter Medical
      • Eppendorf
      • Essen Bioscience/Sartorius
      • Clinical Network Services
      • FloDesign Sonics
      • Fresenius Kabi
      • GE Healthcare
      • HemaCare
      • Invetech
      • InVitria
      • LABS Inc.
      • Lonza
      • Maxcyte
      • MedCision
      • Miltenyi Biotec
      • Polyplus-transfection
      • Quick Pharma Logistics
      • Roche Custom Biotech
      • Saint-Gobain
      • Sartorius
      • Scinogy
      • Thermo Fisher Scientific
      • TouchLight Genetics
      • TrakCel Ltd
      • Vineti, Inc
      • Vironova AB
      • VivaBioCell SpA
      • WuXi AppTec

For more information, and to discuss your needs, please contact Nicola McCall at n.mccall@insights.bio
Tel.: +44 (0)1732 463215

Or complete this form 

Fields marked with an * are required